Article
Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.
Antimicrobial agents and chemotherapy - 1 Sept 2011
Lee Yi-Tzu, Chen Te-Li, Siu Leung-Kei, Chen Chien-Pei, Fung Chang-Phone
Abstract excerpt
An in vivo development of Pantoea agglomerans mutants (isolates PA2 to PA4) with reduced ertapenem susceptibility from that of isolate PA1 was associated with an inadequate clinical response to ertapenem therapy. All four isolates harbored the bla(ACT-9) AmpC β-lactamase gene. However, a loss-of-function mutation in the ampD gene in PA2 to PA4, but not PA1, led to derepressed ACT-9. The reduced ertapenem...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
